李阳，重庆医科大学药学院，副研究员，硕士生导师

电子邮箱：beyond20061330@163.com

教育工作经历

2006/09-2010/06，四川农业大学，药物制剂专业，本科

2010/09-2013/06，沈阳药科大学，药剂学专业，硕士

2013/09-2016/12,沈阳药科大学，药剂学专业，博士

2017/02-2020/09，四川大学，肿瘤学，助理研究员（博士后）

2020/10-至今，重庆医科大学，药学院，副研究员，硕士生导师

研究方向

抗肿瘤脂质体药物的应用基础和转化研究

代表性科研成果：

1.Zheng, Yaxin, Lei Jie, Li Qi, Jin Xuan, LiQingyuan,Li Yang(2021) Interfacial cationization to quicken redox-responsive drug release.Chemical Communications,23, 2943-2946.

2.Zheng, Yaxin，Ying Xue，Su Yue，Jin Xuan，Xu Qiulin，Li Yang（2021）Kinetically-stable small-molecule prodrug nanoassemblies for cancer chemotherapy.International Journal of Pharmaceutics.597. 120369.

3.Li, Yang, Tianyi Kang, Yujiao Wu, Yuwen Chen, Jiao Zhu & Maling Gou* (2018) Carbonate esters turn camptothecin-unsaturated fatty acid prodrugs into nanomedicines for cancer therapy.Chemical Communications.

4.Li, Yang^#, Jiao Zhu^#, Tianyi Kang, Yuwen Chen, Yu Liu, Yulan Huang, Yi Luo, Meijuan Huang & Maling Gou* (2018) Co-assembling FRET nanomedicine with self-indicating drug release.Chemical Communications,54,11618-11621.

5.Li, Yang,Yuwen Chen, Yulan Huang, Wenbi Wu, Yu Liu, Jing Zhang, Meijuan Huang & Maling Gou* (2019) Kinetic stability-driven cytotoxicity of small-molecule prodrug nanoassemblies.Journal of Materials Chemistry B,7,5563-5572.(IF6.331，第一作者，JCR2区)